Relationship between pharmacokinetics and pharmacogenomics, and its impact on drug choice and dose regimens
Author
dc.contributor.author
Martínez Olguín, Matías
Author
dc.contributor.author
Quiñones Sepúlveda, Luis
Admission date
dc.date.accessioned
2024-12-30T18:34:22Z
Available date
dc.date.available
2024-12-30T18:34:22Z
Publication date
dc.date.issued
2024
Cita de ítem
dc.identifier.citation
En: Talevi, Alan, Quiroga, A. M. (eds.) ADME processes in pharmaceutical sciences: dosage, design, and pharmacotherapy. Switzerland: Springer, 2024. 2a. ed. pp. 367-400 DOI: https://doi.org/10.1007/978-3-031-50419-8
es_ES
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/202525
Abstract
dc.description.abstract
Pharmacokinetics can be defined as the relationship between the administered
dose and plasma concentration of a drug, which implies the study of different
processes, such as absorption, distribution, biotransformation, and elimination.
In short, “what the organism does with the drug.” Pharmacokinetics
determine the concentration of drugs in the recipient subject and, therefore,
contribute to the intensity of the response observed. Modifications in pharmacokinetics
help explain different responses between people since there may be
different physiological situations, such as extreme age and organic failure
(renal, hepatic) situations of hypo-hypervolemia. Pharmacokinetics parameters
vary among subjects and also depend on the route of administration
(Fig. 16.1).
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
Springer
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States